growth modulation of nearby parenchymal cells (10,11). For example, several cytokines [e.g. epidermal growth factor, Several structurally dissimilar hypolipidemic drugs, plasticizers and halogenated hydrocarbons induce peroxisomes tumor necrosis factor α (TNFα), hepatocyte growth factor] and eicosanoids (e.g. prostaglandin E 2 ) that are generated in in hepatocytes, and cause hepatocellular adenoma and carcinoma in rats and mice. The mechanism by which the liver primarily by activated Kupffer cells, are direct hepatic mitogens in primary culture systems (12-14). Furthermore, these agents act is unknown, although recent studies have suggested a link between increased cell proliferation and the ability of peroxisome proliferators to stimulate Kupffer cells has recently been established (15). Rates of Kupffer hepatic cancer caused by peroxisome proliferators. Here, we demonstrate that neutralizing antibodies to tumor cell phagocytosis, an index of macrophage activation, were approximately doubled following exposure to nafenopin and necrosis factor α (TNFα) block increases in protein kinase C and cell proliferation due to [4-chloro-6-(2,3-xylidino)-WY-14,643 (15). Additionally, particles formed from the fluorescent peroxisome proliferator LY 171883 were taken up 2-pyrimidinylthio]acetic acid (WY-14,643), a hypolipidemic drug and potent peroxisome proliferator that causes by isolated Kupffer cells leading to activation and production of nitric oxide (16). tumors. WY-14,643 moderately elevated the level of TNFα mRNA in the liver. TNFα was detected immunohistochemiHigh levels of hepatic TNFα are usually associated with septic shock, cytotoxicity, inflammation and apoptosis (17,18).
cally exclusively in Kupffer cells. These results demonstrate that WY-14,643 acts as an indirect mitogen on hepatocytes
However, TNFα plays a role in regulation of liver cell growth which is only now becoming apparent. For example, via TNFα. We propose that the Kupffer cell, a major source of TNFα in the liver, is involved in the mechanism administration of TNFα antibody prior to partial hepatectomy prevented hepatocyte proliferation and liver regeneration in of the mitogenic effect of WY-14,643.
the rat (19). Therefore, the purpose of this study was to determine if TNFα participates in the mitogenic response of WY-14,643 by using an antibody to TNFα in vivo. Introduction Peroxisome proliferators are a group of structurally dissimilar Materials and methods chemicals that include hypolipidemic drugs, plasticizers and herbicides (1-3). Administration of these chemicals to rodents
Experimental design results in proliferation of peroxisomes and increased incidence Male Fischer 344 rats (Charles River Breeding Laboratories) weighing~150 g of hepatocellular carcinoma. Recently, several studies have were maintained on lab chow and tap water ad libitum, and housed with a 12-h day/12-h night cycle. Treated rats were given 100 mg/kg WY-14,643 in suggested that cell replication is a critical event in the mechanolive oil i.g. while control rats received equal amounts of vehicle. 643 ism of peroxisome proliferator-induced hepatocarcinogenesis was obtained from Chemsyn Science Laboratories (Lenexa, KS). All other (4,5). In support of this theory, chronic feeding studies showed chemicals and reagents were purchased at highest available purity from that [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid standard commercial sources.
(WY-14,643*), a hypolipidemic drug which induces peroxi- washing, the antibodies were labeled using the Vectastain Elite Kit (Vector murine TNFα (Genzyme, Cambridge, MA) were used to generate a standard Laboratories) and localized with the peroxidase substrate 6,6Ј-diaminobenzidcurve. Polyclonal antiserum to murine TNFα was prepared by injecting New ine (DAB) enhanced with NiCl 2 . Finally the slides were counterstained with Zealand rabbits with recombinant murine TNFα (a gift from Genzyme) as modified Harris's hematoxylin and dehydrated for mounting. previously described (21). Each rat was administered 0.4 ml of pre-filtered Cell morphology and location were used to identify Kupffer cells since non-immune or immune serum i.p.; the latter represented 500 000 U of large, round cells in the sinusoids take up carbon particles and are therefore antibody (1 U ϭ amount of antibody that neutralizes one bioactive unit of TNF).
most likely Kupffer cells (39) .
5-Bromo-2Ј-deoxyuridine (BrdU) incorporation in hepatocytes
Statistical analysis Formalin-fixed (1%), paraffin-embedded sections of liver tissue from each Unless otherwise indicated, Student's t-test and Dunnett's test were used for sample were incubated with anti-BrdU monoclonal antibody at a dilution of single and multiple comparisons with a common group, respectively, using 1:200 in phosphate-buffered saline, pH 7.4, containing 1% Tween 20 and 1% StatView (Abacus Concepts, Berkeley, CA). Statistically significant differences bovine serum albumin. Biotinylated mouse anti-rat IgG (1:40 dilution in were reported when P Ͻ 0.05. phosphate-buffered saline as described above) was used to detect anti-BrdU binding. Slides were then incubated for 30 min with an avidin-biotin alkaline phosphatase complex. Endogenous alkaline phosphatase was quenched with 14,643 produced a two-fold increase in TNFα mRNA tran- treatment with WY-14,643 as shown by the brown color of peroxidized diaminobenzidine located in the Kupffer cell in Figure 5 . TNFα concentration in serum following administration of WY-14,643 was detected by quantifying cytolytic activity with the L929 target cell line (24). Although low levels of TNFα (0.5 Ϯ 0.2 U/ml) were present in sera of control rats, there incorporation in hepatocytes. Rats were injected with either polyclonal antibodies to TNFα (i.p.) or an equal volume of control rabbit anti-rat was no detectable increase in protein levels in WY-14,643 immunoglobulin G (0.5 ml). One hour later, they were given WY-14,643 in treated rats 2 and 5 h following treatment (data not shown). in this study.
factor. Although ample evidence implicates TNFα as an Discussion inflammatory mediator proximally associated with necrotic injury (18), effects not commonly associated with peroxisome The role of TNFα in hepatic mitogenesis induced by peroxisome proliferators was studied in an animal model using proliferators, the present study indicates that TNFα can also act as a positive modulator of hepatocyte growth. In support neutralizing doses of anti-TNFα antibodies. The results are consistent with the hypothesis that WY-14,643 stimulates of this observation, Akerman et al. (19) showed that antibodies to TNFα inhibited liver regeneration after partial hepatectomy production of low levels of hepatic TNFα by Kupffer cells which acts indirectly as a hepatocyte mitogen. Hepatocyte although they were unable to detect TNFα in the serum. Similarly, pretreatment with endotoxin stimulates TNFα proproliferation is a complex, tightly orchestrated process controlled by hepatocytes and non-parenchymal cells and involves duction and enhances liver regeneration while decreasing endotoxin with polymixin B or endotoxin binding agents cell-to-cell contacts as well as release of various growth factors, such as epidermal growth factor and hepatocyte growth impairs regeneration (25). Furthermore, TNFα can stimulate Five and 24 h after WY-14,643 treatment, TNFα mRNA was an organ with a high rate of cell proliferation, was included on each slide as determined by RT-PCR from isolated RNA as described in Materials and a positive control. Cells that incorporated BrdU were identified by darkly methods (middle panel). G 3 PDH was monitored as a housekeeping gene stained nuclei. Cells were counted in 10 random high power (ϫ400) (bottom panel). All lanes were adjusted to equal RNA concentration and microscope fields per section. The labeling index was calculated by dividing densitometry was used to determine the amount of TNFα message relative the number of labeled nuclei by the total number of nuclei and the result to control (upper panel). All data points are the mean Ϯ SEM for five or six expressed as a percentage. Asterisks denote a significant difference from rats/group; *P Ͻ 0.05 from control at 24 h. control by KruskalϪWallis one-way ANOVA on ranks and Dunn's method on pairwise multiple comparisons. All data points are mean ϮSEM for five or six rats/group; *P Ͻ 0.05. DNA synthesis in normal rat liver (26) and increase mitosis in hepatocytes (14). Additionally, TNFα and IL-1, a cytokine whose release is triggered by TNFα, induce ornithine decarboxylase, an enzyme involved in cell proliferation (27) . Conversely, it has been demonstrated that high concentrations of TNFα impair growth and induce cell death (28) . Therefore, it is likely that TNFα displays a concentration dependent biphasic effect on hepatocytes. In this respect, high concentrations of TNFα induce expression of TNF receptor 1 (TNF-R1; 55 kd) in thymocytes which is responsible for cytotoxic events, while low concentrations stimulate TNF receptor 2 (TNF-R2; 75 kd) expression which is involved in cell proliferation (29) . In human cultures of smooth airway muscle, TNFα inhibits cell proliferation at high concentrations within the range that causes bronchoalveolar inflammation whereas low concentrations stimulate DNA synthesis (30) . Consistent with studies that showed stimulation of cell proliferation with low levels of TNFα, here only moderate increases of TNFα mRNA transcripts were observed in livers of treated animals using the highly sensitive RT-PCR procedure. WY-14,643-induced changes may, however, be underestimated as hepatotoxic the active form of TNFα (37, 38) . We hypothesize that the 
